Alvesco Aerosol, Metered
Product Images NDC 70515-711

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Alvesco (NDC 70515-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Covis Pharma Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of ciclesonide, the active ingredient in Alvesco aerosol inhalation product. The diagram depicts the molecular framework with multiple rings, hydroxyl groups, and ester functionalities characteristic of the corticosteroid molecule.*

FDA Label Image

Figure 1 (Image 02)

A line graph showing the mean change from baseline in FEV1 (liters) prior to AM dose over 16 weeks for Alvesco aerosol inhalation at various dosages compared to placebo. The graph includes data lines for placebo, Alvesco 160 mcg once daily, Alvesco 80 mcg twice daily, and Alvesco 80 mcg twice daily switched to 160 mcg once daily, with measurements plotted at multiple time points and statistical significance indicated.*

FDA Label Image

Figure 2 (Image 03)

Line graph showing the mean change from baseline in FEV1 (L) prior to AM dose over a 12-week period. The graph compares three groups: Placebo, Alvesco 160 µg once daily, and Alvesco 80 µg twice daily, illustrating changes in lung function with week on the x-axis and mean change in FEV1 (L) on the y-axis.*

FDA Label Image

Figure 3 (Image 04)

A line graph showing the mean change from baseline in FEV1 (liters) prior to AM dose over 12 weeks. The variables include Placebo, Alvesco 320 µg/day, and Alvesco 640 µg/day. The graph illustrates changes in lung function measured at intervals of 0, 1, 2, 4, 8, and 12 weeks, with Alvesco treatments demonstrating greater improvements compared to placebo.*

FDA Label Image

Figure A (Image 05)

Illustration diagram of an Alvesco inhaler showing key parts: canister, actuator, mouthpiece cap, and a dose indicator with display window. The top view highlights the dose indicator display window with a 'press here' label for operation, and the side view labels the components of the metered aerosol inhaler device.*

FDA Label Image

Figure B (Image 06)

An instructional line drawing labeled 'Figure B' showing a person holding an Alvesco inhaler in one hand, with the thumb pressing down on the canister to release aerosol medication. The illustration depicts the correct technique for activating the inhaler by pressing the top and shows aerosol spray emitted from the inhaler nozzle.*

FDA Label Image

Figure C (Image 07)

An instructional illustration showing a hand holding an Alvesco inhaler with the thumb pressing the mouthpiece. An arrow indicates the direction to pull the mouthpiece, demonstrating how to open or prepare the metered-dose aerosol inhaler for use.*

FDA Label Image

Figure D (Image 08)

Illustration showing a hand holding an Alvesco aerosol inhaler in the correct position for inhalation use, demonstrating the proper grip and orientation for respiratory delivery of ciclesonide.*

FDA Label Image

Figure E (Image 09)

An instructional illustration showing a person using an Alvesco inhaler by placing the mouthpiece in the mouth and preparing to inhale the medication. The image emphasizes the proper hand positioning and inhaler placement for respiratory administration.*

FDA Label Image

Figure F (Image 10)

An instructional illustration showing a person using a metered-dose inhaler. The individual is depicted holding the inhaler with one hand, exhaling through the mouth, indicating how to properly inhale the aerosol medication.*

FDA Label Image

Figure G (Image 11)

An instructional diagram labeled 'Figure G' showing two hands holding an Alvesco inhaler. One hand grips the inhaler upright while the other hand positions a spacer device onto the mouthpiece, illustrating proper assembly for respiratory aerosol administration.*

FDA Label Image

Figure H (Image 12)

Illustration showing a person holding an Alvesco aerosol inhaler, focusing on the bottom where a small circular indicator or valve is highlighted by a magnified view. The image emphasizes a specific feature or part of the inhaler for instructional purposes.*

FDA Label Image

Figure I (Image 13)

An illustration showing an Alvesco inhaler device and a close-up view of its dose counter. The dose counter displays the number '0', indicating no doses remaining. The inhaler is a metered aerosol for respiratory (inhalation) use containing ciclesonide, labeled by Covis Pharma US, Inc.*

FDA Label Image

Principal Display Panel (80 mcg Carton)

Packaging label for Alvesco 80 mcg/actuation inhalation aerosol by Covis Pharma US, Inc. The label shows the product name, active ingredient ciclesonide, dosage form as inhalation aerosol, and strength of 80 micrograms per actuation. The net contents are 6.1 g with 60 metered actuations. The label also includes usage warnings, storage instructions, and manufacturer information noting it is made in the United Kingdom for Covis Pharma in Switzerland.*

FDA Label Image

Principal Display Panel (160 mcg Carton)

Alvesco 160 mcg/actuation inhalation aerosol packaging label for a 6.1 g canister providing 60 metered actuations. The label displays the brand name Alvesco, generic name ciclesonide, and dosage strength prominently. Manufactured for Covis Pharma US, Inc, with storage and safety instructions noted. The product is indicated for oral inhalation with the specified actuator only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.